| Generic Available |
|
Yes |
 |
| Pharmacological Index |
|
Trace Element |
|
| Use |
|
Cofactor for replacement therapy to different enzymes helps maintain normal growth rates, normal skin hydration and senses of taste and smell |
|
| Pregnancy Risk Factor |
|
C |
|
| Adverse Reactions |
|
<1%: Gastrointestinal: Indigestion, nausea, vomiting Hematologic: Neutropenia, leukopenia Hepatic: Jaundice Respiratory: Pulmonary edema |
|
| Usual Dosage |
|
Clinical response may not occur for up to 6-8 weeks Premature Infants <1500 g, up to 3 kg: 300 mcg/kg/day Full-term Infants and Children less than or equal to 5 years: 100 mcg/kg/day Adults: Stable with fluid loss from small bowel: 12.2 mg zinc/liter TPN or 17.1 mg zinc/kg (added to 1000 mL I.V. fluids) of stool or ileostomy output Metabolically stable: 2.5-4 mg/day, add 2 mg/day for acute catabolic states |
|
| Dental Health: Local Anesthetic/Vasoconstrictor Precautions |
|
No information available to require special precautions |
|
| Dental Health: Effects on Dental Treatment |
|
No effects or complications reported |
|
| Nursing Implications |
|
Patients on TPN therapy should have periodic serum copper and serum zinc levels |
|
| Dosage Forms |
|
Injection: 1 mg/mL (10 mL) |
|
|
Copyright © 2007 Drugs Area |
